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ABSTRACT 13 
Tetrahydrocurcumin (THC) is one of the major colourless metabolites of curcumin and 14 
shows even greater pharmacological and physiological benefits. The aim of this work was 15 
the manufacturing of porous scaffolds as a carrier of THC under physiological conditions. 16 
Fish-derived gelatin scaffolds were prepared by freeze-drying by two solutions 17 
concentrations (2.5% and 4% w/v), cross-linked via addition of lactose and heat-treated 18 
at 105 °C. This cross-linking reaction resulted in more water resistant scaffolds with a 19 
water uptake capacity higher than 800%. Along with the cross-linking reaction, the gelatin 20 
concentration affected the scaffold morphology, as observed by scanning electron 21 
microscopy images, by obtaining a reduced porosity but larger pores sizes when the initial 22 
gelatin concentration was increased. These morphological changes led to a scaffold’s 23 
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strength enhancement from 0.92±0.22MPa to 2.04±0.18MPa when gelatin concentration 24 
was increased. THC release slowed down when gelatin concentration increased from 2.5 25 
to 4%w/v, showing a controlled profile within 96 h. Preliminary in vitro test with 26 
chondrocytes on scaffolds with 4%w/v gelatin offered higher metabolic activities and cell 27 
survival up to 14 days of incubation. Finally the addition of THC did not influence 28 
significantly the cytocompatibility and potential antibacterial properties were 29 
demonstrated successfully against Staphylococcus aureus. 30 
KEYWORDS: Tetrahydrocurcumin; gelatin; lactose; scaffolds; antibacterial. 31 
1. Introduction 32 
Porous scaffolds are crucial for many biomedical and biological applications [1, 2]. In 33 
tissue engineering, compared with synthetic materials, natural polymers have been 34 
shown to favourably regulate division, adhesion, differentiation and migration of cells [3]. 35 
Gelatin was chosen as a base material because it is biocompatible, biodegradable, non-36 
carcinogenic, less antigenic than collagen, and commercially available at relatively low 37 
cost [4, 5]. Moreover, it is recognised as safe material by the Food and Drug 38 
Administration. Therefore, porous gelatin scaffolds have found many applications in 39 
tissue engineering research, e.g. for bone, skin, cartilage and nerve regeneration [6-10]. 40 
In particular, tissue engineering of articular cartilage in vitro is a promising strategy for 41 
cartilage repair, in order to tackle the difficulties related with the self-repair of articular 42 
cartilage due to its avascular tissue nature, low rate of chondrocyte proliferation and 43 
matrix turnover [11]. Porous scaffolds are used to support cell adhesion and proliferation 44 
and to guide formation of cartilage tissue. However, in vitro engineered cartilage often 45 
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has thickness limitation, heterogeneous cartilage extracellular matrix (ECM) and weak 46 
mechanical property which limit their clinical application [12, 13].  47 
In order to preserve structure and provide mechanical support to cells during tissue 48 
formation [14], a cross-linking of gelatin is required. Chemical cross-linking methods 49 
typically use chemicals such as aldehydes, aspartic and glutamic acids [15]. Additionally, 50 
physical cross-linking methods, such as heating, drying, and irradiation, are also 51 
commonly applied to proteins [16, 17]. In particular, in this work we considered the effect 52 
of heating in the presence of sugars on modifying the conformation and interactions within 53 
proteins, leading to a complex cross-linking process known as Maillard reaction or non-54 
enzymatic glycation. The main variables affecting the extension of the Maillard reaction 55 
are temperature, time, initial pH, carbonyl/sugar ratio, and water activity [18-20]. So, these 56 
factors should be analysed in order to obtain the properties required for biomedical 57 
applications. 58 
Additionally, gelatin-based scaffolds can be used as a vehicle for the release of 59 
bioactive agents such as antioxidants, peptides, growth factors, antimicrobials and drugs 60 
[21-24]. In particular, infection is a major problem in orthopaedics leading to implant 61 
failure. Sources of infectious bacteria include the environment of the operating room, 62 
surgical equipment, clothing worn by medical and paramedical staff, resident bacteria on 63 
the patient's skin and bacteria already residing in the patient’s body [25]. Implant-64 
associated infections are the result of bacteria adhesion to an implant surface and 65 
subsequent biofilm formation at the implantation site [26]. In this work, we decided to 66 
evaluate the antibacterial properties of the crosslinked gelatin scaffolds with the 67 
incorporation of tetrahydrocurcumin (THC), a water-soluble, colourless and tasteless 68 
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antioxidant, antidiabetic, anticancer and anti-inflammatory plant-derived compound, that 69 
is increasingly being used for pharmaceutical, medical and food applications [27, 28]. 70 
Literature reports only studies on the delivery of the hydrophobic compound curcumin to 71 
facilitate wound healing with the addition of ethanol in chitosan-alginate sponges [29] or 72 
cyclodextrins in slightly hydrated alginate foams in order to improve the distribution of 73 
curcumin [30]. 74 
Therefore, beyond the state of the art, this is the first work where gelatin-based 75 
scaffolds, prepared by freeze-drying, were cross-linked by using lactose. Lactose is a 76 
disaccharide occurring almost exclusively in the milk of mammals with important 77 
nutritional and probiotic properties and is mainly used in various food, nutrition and 78 
pharmaceutical formulations [31]. In this study, lactose was used as a cross-linker in order 79 
to promote the Maillard reaction, between the carbonyl group of lactose and the gelatin 80 
amino group, and to improve the mechanical stability of the gelatin scaffolds. 81 
Furthermore, THC was added to the initial gelatin solution to analyse the release of the 82 
bioactive compound from the gelatin scaffold and its antibacterial effect in the presence 83 
of the common nosocomial and joint-replacement/ wound infecting organisms 84 
Pseudomonas aeuroginosa and Staphylococcus aureus. 85 
This work aimed at studying the effect of initial gelatin concentration, cross-linking 86 
reaction and THC addition on the physico-chemical, mechanical and biological 87 
characteristics of porous gelatin scaffolds as potential medical device in musculoskeletal 88 
tissue regeneration.  89 
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2. Materials and methods 90 
2.1 Materials 91 
A commercial cod fish gelatin type A was employed in this study. It has bloom 200, 92 
11.06% moisture and 0.147% ash. Fish gelatin was kindly supplied by Weishardt 93 
International (Liptovsky Mikulas, Slovakia) and meets the quality standard for edible 94 
gelatin (1999/724/CE). Glycerol and lactose (Panreac, Barcelona, Spain) were used as 95 
plasticizer and cross-linking agent, respectively. Tetrahydrocurcumin was gifted by 96 
Sabinsa Corporation (East Windsor, New Jersey, USA) and was used as bioactive agent. 97 
2.2 Scaffold preparation  98 
2.5 and 4% w/v fish gelatin porous scaffolds were prepared by freeze-drying. Firstly, 99 
2.5 g or 4 g gelatin and 20 wt% lactose (on gelatin dry basis) were dissolved in 100 mL 100 
distilled water for 30 min at 80 °C under continuous stirring to obtain a homogenous blend. 101 
After that, a mixture of 10 wt% glycerol and 5 wt% THC (on gelatin dry basis) was added 102 
to the solution, pH was adjusted to 10 with 1 N NaOH and the solution was placed in an 103 
ultrasonic device (USC300TH, VWR International, USA) at room temperature for 5 min. 104 
Subsequently, the solution was maintained at 80 ºC for 30 min under stirring, 2 mL 105 
solution was poured into each well of a 24 multiwell plate (Costar 3526, Corning 106 
Incorporated, USA) and the plate was kept in the fridge at 4 ºC to cool down. Once the 107 
solution was gelled, the plate was kept in a freezer at -20 ºC for 48 h and then, freeze-108 
dried for 48 h (Alpha 1-2 LDplus, CHRIST, Germany). Finally, non-heated (NH) scaffolds 109 
were taken out from the wells and 1 day later some of them were heat-treated (HT) at 110 
105 ºC for 24 h in an oven (Carbolite 3000, Carbolite Gero, UK) in order to promote the 111 
Maillard cross-linking reaction [32-34]. As verified in a previous work [27], these 112 
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conditions do not affect the thermal stability of gelatin and THC. The samples containing 113 
THC and heat-treated were coded as HT-THC. 114 
2.3 Attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy 115 
FTIR spectra were obtained using a Spectrum Two PE instrument equipped with a 116 
horizontal attenuated total reflectance (ATR) crystal (ZnSe) (PerkinElmer Inc., USA). The 117 
samples were placed directly onto the ATR crystal and spectra were collected in 118 
transmittance mode. Each spectrum was the result of the average of 32 scans at 4 cm−1 119 
resolution. Measurements were recorded in the wavelength range of 1800-800 cm−1. All 120 
spectra were smoothed using the Savitzky-Golay function. Second-derivative spectra of 121 
the amide region were used at bands position guides for the curve fitting procedure, using 122 
OriginPro 9.1 software. 123 
2.4 Compression test 124 
Mechanical tests were performed using a mechanical testing machine (EZ-SX, 125 
Shimadzu, Japan) equipped with a 500 N load cell, as described in a previous work [35]. 126 
Test specimens were cylinder-shaped scaffolds with a 1.3 cm diameter and an average 127 
height of around 1 cm. The crosshead speed was set at 1 mm·min−1, and the load was 128 
applied until the specimen was compressed to around 80% of its original height before 129 
break. Compression resistance of five dried samples for each composition was evaluated 130 
at room temperature and the stress was calculated by dividing the applied force with the 131 
initial scaffold surface area, whereas strain was calculated from the displacement of the 132 
scaffolds in relation to the original thickness. Young’s modulus (E) was also calculated as 133 
the slope of the linear elastic regime (0-15%). 134 
2.5 Scanning electron microscopy (SEM) 135 
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SEM (Hitachi TM3030 Tabletop, Germany) equipped with Energy Dispersive 136 
Spectroscopy (EDS) was utilised to study the scaffold inner morphology. The samples 137 
were cut into small squares, fixed on the aluminium stub using carbon tape. For pore size 138 
evaluation SEM images were analysed by ImageJ software. 139 
2.6 Water uptake (WU) measurements 140 
WU was calculated gravimetrically according to ASTM D570-98 [36] under physiological 141 
conditions. Three specimens of each composition were weighed (W0) and immersed in 6 142 
mL of a phosphate buffered saline (PBS) solution at pH 7.0 in order to determine the WU 143 
profile at 37°C in an incubator (INCU-Line, VWR). Then, the samples were removed from 144 
the buffer solution at fixed times, wiped with a paper and reweighed (W t). WU was 145 
calculated using the following equation [37]: 146 
WU (%)=
Wt-W0
W0
×100          Eq.1 147 
A graph depicting WU against time was plotted in order to determine the equilibrium 148 
swelling. 149 
2.7 Degradation test 150 
The degradation degree (DD) was calculated gravimetrically under physiological 151 
conditions. Three specimens of each composition were weighed (WI) and immersed in 6 152 
mL of a PBS solution at pH 7.0 in order to determine the degradation at 37 °C in an 153 
incubator. Samples were removed from the buffer solution once swelling test ended, 154 
wiped with a paper, left to dry at room temperature for 24 h and reweighed (WF). DD was 155 
calculated using the following equation: 156 
DD (%)=1-
WF
WI
×100          Eq.2 157 
2.8 THC release 158 
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UV-Vis spectroscopy is one of the methods to determine the release and concentration 159 
of bioactives in buffer solutions. Firstly, the wavelength of maximum absorbance for THC 160 
in PBS was measured (ʎmax 280 nm) and then, standard solutions of THC were prepared 161 
over a concentration range (0.31250-0.00977 mg/mL) to establish a calibration curve 162 
(y=0.0314 + 2.2012x, R2=0.9985).  163 
THC release was determined by immersion of a quarter of a scaffold in 6 mL of a PBS 164 
solution (pH 7.0) at 37 °C in an incubator. At particular time intervals (1, 2, 4, 8, 24, 28 165 
and 96 h), aliquots of buffer (3 mL) were withdrawn, replaced with fresh buffer and 166 
analysed by UV–Vis spectroscopy (Lambda 2S Perkin Elmer) at 280 nm. All tests were 167 
carried out in triplicate and the results were expressed as % of released THC with respect 168 
to the THC incorporated in the scaffold by employing the calibration curve. 169 
2.9 Biological characterisation 170 
2.9.1 Cell culture 171 
Chondrocytes cells were differentiated from Human Bone Marrow Stromal Cells (Y201) 172 
and cultured according the protocol described by Genever et al.[38] at 37 °C, 5% CO2, in 173 
Chondrocyte Growth Medium ready-to-use (PromoCell, UK). 174 
In order to perform biocompatibility assays, the scaffolds were prepared according the 175 
same procedure explained in 2.2 section with few modifications. Once gelatin solution 176 
was prepared, 1 mL was poured into each well of a 48 multiwell plate in order to get 177 
smaller scaffolds, which were subsequently cut in samples of 8 mm diameter and an 178 
average height of around 2.5 mm. Each sample was put into a membrane-based cell 179 
culture insert (Millicell, membrane pore size of 0.8 µm, Merck, Millipore, Germany). This 180 
insertion was carried out in a class 2 laminar flow hood and each insert was placed in a 181 
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well of a 24 multiwell plate. Afterwards, the plate was placed below the UV light for 30 182 
min in order to keep it sterile. A suspension of 20x104 cells in Growth medium was seeded 183 
dropwise (in 500 µL) on the top surface of the scaffolds and incubated at 37 °C, 5% CO2 184 
for 30 min. Then, fresh medium was added up to1 mL volume. 185 
2.9.2 Cytocompatibility study 186 
The Presto Blue assay was exploited to test the metabolic activity of cells seeded on 187 
the scaffolds after 1, 3, 7 and 14 days of culture. A LS-50B Luminescence Spectrometer 188 
(Perkin Elmer, Waltham, MA) was used to measure the fluorescence (560 nm excitation 189 
and 590 nm emission) after 5 h of incubation with a 10% aliquot of Presto Blue (Thermo 190 
Scientific, USA). The obtained values were corrected subtracting the average 191 
fluorescence of control wells. Results were expressed as mean ± standard deviation. 192 
2.9.3 Cell fixation and probe staining for confocal microscopy 193 
Three and seven days after seeding cells on the scaffolds, cells were fixed using 4% 194 
paraformaldehyde (Sigma Life Science) for 15 min at room temperature. Cells were 195 
washed three times using 0.1% DPBS/Tween 20 (Sigma Life Science), followed by a 20-196 
min light-protected incubation period at room temperature with phalloidin (1 mg/mL, 197 
Sigma Life Science). After three new washes with 0.1% DPBS/Tween 20, 4′,6-diamidino-198 
2-phenylindole (DAPI; 1:2500 solution, Vector Laboratories) was added, and the solution 199 
was subjected to a 10-min light-protected incubation period at room temperature. 200 
Afterwards, cells were washed and resuspended in 500 μL of 0.1% DPBS/Tween 20. 201 
Fixed cells were protected from light and stored at 4 °C. Cells were visualised using a 202 
Leica TCS SP2 UV AOBS MP (Upright) point scanning confocal microscope (Leica 203 
Microsystems) at 20× magnification. 204 
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2.10 Antibacterial tests 205 
Antimicrobial activity of the scaffolds was tested against Staphylococcus aureus (S. 206 
aureus) NCTC 8325 and a clinical strain of Pseudomonas aeruginosa (P. aeruginosa) 207 
(SOM-1, Stafford group culture collection). Fresh 4 h cultures of S. aureus strain 8325 208 
and a clinical P. aeruginosa isolate (Sheffield culture collection) were grown in Brain Heart 209 
Infusion broth (Oxoid) at 37°C (OD600 0.4-0.6) and spread onto Columbia nutrient agar 210 
plates. After drying for 10 min, 8 mm HT gelatin scaffolds of both concentration with or 211 
without THC were placed on the surface of the agar plates, which were then incubated 212 
for 24 h at 37 °C before being photographed. 213 
2.11 Statistical analysis 214 
Data were subjected to one-way analysis of variant (ANOVA) by means of a SPSS 215 
computer program (SPSS Statistic 20.0). Post hoc multiple comparisons were determined 216 
by the Tukey’s test with the level of significance set at *p < 0.05 and **p < 0.01. 217 
3. Results and discussion 218 
3.1. Physicochemical characterisation 219 
ATR-FTIR analysis was carried out in order to evaluate the gelatin-lactose and gelatin-220 
THC interactions. The relative spectra are shown in Figure 1A and 1B. The main 221 
absorption bands were located in the spectral range from 1630 to 800 cm-1. Gelatin bands 222 
were related to C=O stretching at 1630 cm-1 (amide I), N-H bending at 1530 cm-1 (amide 223 
II) and C-N stretching at 1230 cm-1 (amide III) [39]. The main absorption bands of glycerol 224 
were related to the five peaks corresponding to the vibrations of C-C bonds at 850, 940 225 
and 1000 cm-1 and C-O bonds at 1050 and 1100 cm-1 [40]. The bands associated with 226 
lactose were located between 1180 and 953 cm-1, where the bands at 979 and 987 cm-1 227 
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were referred to the vibration of C-C, and the band at 1034 cm-1 was associated with the 228 
vibration of C-O in CH2-OH group [41]. Finally, the characteristic bands of THC 229 
corresponding to C=C stretching of aromatic rings (1600-1400 cm−1) and associated to 230 
C-O stretching of hydroxyl groups (1300-1000 cm−1) cannot be clearly distinguished due 231 
the overlapping with the bands of gelatin and glycerol [42]. 232 
As can be observed in Figure 1A and 1B, the two bands situated in the range of 1100-233 
1000 cm-1 tend to become a single band in HT scaffolds irrespective of gelatin 234 
concentration, indicating the chemical reaction between gelatin and lactose, as shown in 235 
previous works [32, 33]. As can be seen in Scheme 1, this cross-linking reaction is a 236 
condensation reaction between the carbonyl group of lactose and the amino group of 237 
gelatin, mainly the amino group of lysine [43, 44]. 238 
Regarding THC addition, the band corresponding to amide II showed a shoulder at 239 
lower frequencies, attributed to the hydrogen bonding between the hydroxyl groups of 240 
THC and the amino groups of proline and hydroxyproline in gelatin [45]. Additionally, the 241 
bands in the range of 1100-1000 cm-1 were clearly distinguishable, indicating that THC 242 
addition could hinder the chemical reaction between gelatin and lactose due to steric 243 
hindrance. The band corresponding to amide I depends on the secondary structure of the 244 
protein backbone and is the most commonly used band for the quantitative analysis of 245 
conformational changes [46]. Therefore, the areas of the bands at 1624 cm-1, 1650 cm-1, 246 
and 1680 cm-1 as a function of protein concentration and heat treatment were measured 247 
and shown in Figure 1C. As can be observed, the protein concentration did not have 248 
great influence on NH scaffolds; however, it affected the secondary structure of the 249 
protein in HT scaffolds. The increase of the bands at 1624 cm-1 and 1680 cm-1 in HT 250 
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scaffolds with 4% w/v gelatin could be related to a higher cross-linking degree in the 251 
scaffolds with higher gelatin content. Regarding THC addition, the secondary structure of 252 
the protein was affected to a lesser extent. This behaviour could be associated with a 253 
lower cross-linking degree due to the fact that THC could hinder the cross-linking reaction, 254 
irrespective of gelatin concentration. 255 
Freeze-drying is a process in which a solvent is removed from a frozen product by a 256 
sublimation process under vacuum, the removal of water could be influenced by the initial 257 
gelatin concentration. As the dry product has smaller specific area at higher solute 258 
concentrations, the removal of the absorbed water is more difficult (Figure S1), requiring 259 
longer times to finish the secondary drying step [47]. Thus, the amount of residual water 260 
present in gelatin scaffolds after freeze-drying could vary as a function of the initial gelatin 261 
concentration, having a significant impact on the extension of cross-linking reaction. In 262 
fact, moisture content is believed to be an important factor since moisture can increase 263 
chains' mobility and, thus, the rate of chemical reaction [48].  264 
3.2. Mechanical and morphological characterisation 265 
In order to assess the effects of the initial gelatin concentration, THC addition and cross-266 
linking on mechanical properties of the scaffolds, the stress-strain curves, obtained by 267 
compression tests at 0-80% strain, were analysed and the results are shown in Figure 268 
2A. All the samples presented the typical trend of porous scaffolds, in which the stress-269 
strain curve is comprised of three regions with different mechanical behaviour: (i) the 270 
linear proportion of the stress-strain curve at low strain values is related to the elastic 271 
behaviour of the material; (ii) the region at intermediate strain values is related to the 272 
viscoelastic behaviour of the scaffold; and (iii) the curve at high strain values is related to 273 
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the densification process [49]. It is worth noting that increasing the initial gelatin 274 
concentration and promoting the cross-linking reaction by heating notably reinforced the 275 
scaffolds, indicating the relevance of these two factors[50]. As can be seen in Figure 2B, 276 
the stress values at 40% strain for the gelatin scaffolds without THC were significantly (p 277 
< 0.05) different. In fact, the strength enhancement with respect to NH scaffolds with 2.5% 278 
w/v gelatin was 134% for HT scaffolds with 2.5% w/v gelatin, 163% for NH scaffolds with 279 
4% w/v gelatin, and 218% for HT scaffolds with 4% w/v gelatin. Regarding THC addition, 280 
a decrease in the scaffold reinforcement was observed, which could be related to a lower 281 
cross-linking degree between gelatin and lactose, as shown by ATR-FTIR. In fact, at 40% 282 
strain, the stress values of HT-THC scaffolds with 2.5% w/v gelatin and 4% w/v gelatin 283 
were significantly (p < 0.05) lower than those of HT scaffolds. 284 
The Young’s modulus of each scaffold was also calculated. Although 2.5% w/v scaffolds 285 
did not show significant (p > 0.05) changes after both heat treatment and THC addition, 286 
scaffolds prepared with 4% w/v gelatin presented a significant (p < 0.05) increase after 287 
heat treatment. This could be due to a higher degree of cross-linking between gelatin and 288 
lactose. However, the addition of THC slightly decreased the modulus value due to its 289 
possible effect in slowing down the cross-linking reaction. However, the obtained 290 
scaffolds presented suitable mechanical properties for cartilage tissue engineering 291 
applications [51-53]. 292 
As freeze-drying is one of the most effective methods to create numerous cavities within 293 
the bulk material, SEM analysis was performed on the fractured sections of the scaffolds 294 
to evaluate the effect of the initial gelatin concentration, THC addition and the heat 295 
treatment on the morphology and porosity of the scaffolds (Figure 3). It is worth 296 
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mentioning that the initial gelatin concentration notably affected the scaffolds porosity. NH 297 
samples prepared with 2.5% w/v gelatin (Figure 3A) presented a homogeneous porous 298 
matrix with small pores, which could provide more surface area for cell adhesion. In 299 
contrast, a less porous structure with larger pores was shown when gelatin concentration 300 
was increased up to 4% w/v (Figure 3D); this could facilitate nutrition supply and waste 301 
removal [54]. The porosity and the pore size of the scaffolds fabricated by freeze-drying 302 
are largely dependent on parameters such as the water:polymer ratio and the viscosity of 303 
the solution [55]. In fact, when the initial gelatin concentration increased, the volume 304 
fraction occupied by the material itself also increased, affecting the porosity of the material 305 
[56]. Regarding heat treatment (Figure 3B and E), the reaction between gelatin and 306 
lactose led to more porous structures, which presented lower pore size when THC was 307 
added (Figure 3C and F) mainly in 4% w/v gelatin scaffolds. 308 
As the distribution of the pore sizes is influenced by the composition, ImageJ computer 309 
software was used to analyse SEM images and measure the pore sizes by means of an 310 
estimation of the cross-sectional area of the scaffold [57]. Figure 4A shows the average 311 
pore size of the scaffolds as a function of initial gelatin concentration, THC addition and 312 
heat treatment. As can be observed, 2.5% w/v scaffolds did not present notable changes 313 
in the average pore size while an increase in pore size was observed when initial gelatin 314 
concentration increased. In fact, NH and HT samples prepared with 4% w/v gelatin 315 
presented 2- and 3-fold average pore size with larger pores ( 197 µm and 170 µm ) than 316 
NH and HT 2.5% w/v scaffolds ( 86 µm and 65 µm), respectively. Regarding THC 317 
addition, samples prepared with 2.5% w/v gelatin did not present significant (p > 0.05) 318 
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changes while 4% w/v scaffolds pore size notable decreased. This could be related to a 319 
higher volume occupied by the material in samples prepared with 4% w/v gelatin.  320 
The mean pore size distribution of the scaffolds as a function of initial gelatin 321 
concentration, THC addition and heat treatment is shown in Figure 4B. In the case of 322 
NH, HT and HT-THC scaffolds prepared with 2.5% w/v gelatin, around 74%, 66% and 323 
62% of pores were in the size range of 50-100 µm, respectively. When gelatin 324 
concentration was increased, it was observed a large number of pores in the size ranges 325 
of 150-250 µm, 100-250 µm and 50-150 µm. These results indicated that gelatin 326 
concentration, THC addition and heat treatment notable affected the pore size distribution 327 
of scaffolds. Thus, NH and HT 4% w/v scaffolds showed bigger pore size, which could 328 
explain lower deformation values [10], as shown by compression results. Regarding THC 329 
addition, a decrease in pores size was observed which could be related to a higher 330 
compaction of these scaffolds.  331 
3.3. Water uptake, degradation and THC release 332 
WU measurements were carried out in order to determine the effect of the initial gelatin 333 
concentration, THC addition and the heat treatment on the water absorption capacity of 334 
the scaffolds. As can be observed in Figure S2, NH scaffolds with 2.5% w/v gelatin were 335 
completely dissolved after 30 min of immersion in PBS at 37 ºC and considered not 336 
suitable, while HT and HT-THC scaffolds with 2.5% w/v gelatin maintained their physical 337 
integrity, demonstrating the effect of heating to promote cross-linking reaction [32]. Similar 338 
behaviour was observed for the scaffolds with 4% w/v gelatin (data not shown). 339 
WU capacities of HT and HT-THC scaffolds were analysed as a function of gelatin 340 
concentration and the results are shown in Figure 5. As can be seen, gelatin 341 
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concentration notably affected the WU capacity. Although both HT scaffolds increased 342 
their weight up to 400% after only 1 h of incubation in PBS, 4% w/v scaffolds (Figure 5B) 343 
took twice as long (48 h) to reach the same WU ( 770%) as the 2.5% w/v scaffolds 344 
(Figure 5A). However, WU results showed high absorption capacity (> 800%) for the 345 
scaffolds prepared with both concentrations. These WU results showed that the scaffolds 346 
were hydrophilic in nature with capacity to hold a large amount of water molecules. 347 
However, the ability of the scaffold to hold water molecules within its network is dependent 348 
on the architecture of the scaffolds [58]. The longer stability of HT scaffolds with 4% w/v 349 
gelatin in PBS at 37 ºC could be related to a higher cross-linking degree, lower porosity 350 
and higher compaction, which could slow down the absorption of liquid, leading to longer 351 
times (> 336 h) than the scaffolds with 2.5% w/v (72 h) before complete dissolution. 352 
With regard to THC addition, an increase in the scaffold WU capacity was observed, 353 
irrespective of gelatin concentration. In fact, WU values of the scaffolds with 4% w/v 354 
gelatin increased up to 843 ± 20%, while the values of the scaffolds with 2.5% w/v gelatin 355 
presented a higher capacity to retain water (946 ± 72%) after 48 h of incubation. This 356 
faster WU for HT-THC scaffolds with 2.5% w/v gelatin can be due to the lower cross-357 
linking degree and compaction of these scaffolds. It is also worth noting that the addition 358 
of THC facilitated the disintegration of scaffolds. 359 
Scaffold degradation degree (DD) was calculated as well and the results are shown in 360 
Figure 5C. With respect to NH scaffolds, DD values notably decreased up to 67.5 ± 0.2% 361 
and 12.1 ± 2.5% for the HT scaffolds with 2.5 and 4% w/v gelatin, respectively, after 72 362 
and 336 h of incubation in PBS at 37 ºC. This decrease was related to the cross-linking 363 
reaction between gelatin and lactose. Since the degree of cross-linking and compaction 364 
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were higher for the scaffolds with 4% w/v gelatin, as shown by ATR-FTIR and SEM 365 
results, these scaffolds showed lower DD values. Regarding THC addition, the scaffolds 366 
with 2.5% w/v gelatin were totally degraded, while the scaffolds with 4% w/v gelatin 367 
presented a degradation value of 54.6 ± 5.6% after 72 and 336 h of incubation in PBS, 368 
respectively. As previously explained, the increase in the degradation values of HT-THC 369 
scaffolds could be related to a lower extension of the cross-linking reaction due to 370 
formation of physical bonds between the hydroxyl groups of THC and the amino groups 371 
of proline and hydroxyproline in gelatin, which could hinder the cross-linking reaction, 372 
resulting in higher DD values of HT-THC scaffolds than those of HT scaffolds. 373 
Finally, the THC release was analysed by UV-Vis spectroscopy and the results are 374 
shown in Figure 6. As can be seen, in the first 8 h 82 ± 4% THC was released from 2.5% 375 
w/v scaffolds while 64 ± 9% was released from 4% w/v scaffolds. This decrease in THC 376 
release could be due to a higher physical interaction between gelatin and THC, a more 377 
extensive chemical reaction and a higher structural compaction in 4% w/v scaffolds that 378 
slowed down the release of the bioactive. The high release of the anti-inflammatory 379 
bioactive in the first 8 h could contribute to reduce the early postoperative inflammation, 380 
improving the cartilage healing. Furthermore, the release of THC from scaffolds continued 381 
increasing slightly over time since 2.5% w/v scaffolds presented a complete THC release 382 
after 96 h of immersion due to scaffolds total degradation while 4% w/v scaffolds showed 383 
a lower THC release values (79 ± 9%). This controllable long release of the anti-384 
inflammatory compound could be an effective intra-articular drug delivery method for the 385 
postoperative inflammation and pain management [59]. 386 
3.4. Biological characterisation 387 
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Due to the poor water stability of NH scaffolds, the biological characterisation was only 388 
carried out for HT and HT-THC scaffolds as a function of gelatin concentration in order to 389 
analyse the viability of those scaffolds as cell substrate materials. Cell metabolic activity 390 
as well as cell morphology are shown in Figure 7. The metabolic activity on both gelatin 391 
concentrations presented a similar behaviour being higher for the 2.5% w/v scaffolds 392 
without the presence of THC. The seeded chondrocytes presented their metabolic activity 393 
peak on day 7, decreasing afterwards due to the high cell confluence (as statistically 394 
significantly evident for the control represented by cells seeded on Tissue Cultured Plate, 395 
TCP). It is important to note that the metabolic activity on THC scaffolds was lower due 396 
to the THC presence; however, once released (approximately 98 h as shown previously 397 
in section 3.3), cells achieved their maximum metabolic activity. This is also related to the 398 
lower metabolic activity observed in the 4% w/v scaffolds, since their THC release was 399 
slower when compared to the 2.5% w/v scaffolds. 400 
Phalloidin and Dapi stainings was performed to study the cell morphology and 401 
organisation within the different scaffolds. As shown in Figure 7, the cells seeded in both, 402 
2.5 and 4% gelatin scaffolds, showed a high metabolic activity and spreading at day 3; 403 
particularly with visualisation of typical polygon shape of young chondrocytes at 4% 404 
gelatin [60, 61]. Subsequently, as the cells proliferated, it was possible to observe the 405 
formation of cellular clusters in the 4% w/v scaffolds, either in presence and absence of 406 
THC, upon 7 days of culture. Furthermore, cultured cells were gradually aggregating, 407 
retaining typical polygons shapes and creating large interspaces; suggesting a potential 408 
formation of lacuna-like cartilage [62]. In contrast, the cells in the TCP control and 2.5% 409 
gelatin groups showed lower expression of F-actin (phalloidin staining). This could be 410 
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induced by the different level of gelatin and/or its biomechanical effects closer to natural 411 
cartilage tissues, by providing an environment with more favourable chondrogenic 412 
properties [63]. It is also verified that both gelatin concentrations, with or without THC, 413 
showed healthy and proliferating cells in the developed scaffolds. Interestingly, the 414 
stability and metabolic activity of the scaffolds in growth media improved up to 2 weeks 415 
when compared to TCP control group, and it could be that the specific biological 416 
properties of gelatin to promote cell adhesion and cell-maritx interactions enhanced the 417 
biological stability of scaffolds [64]. 418 
3.5. Antibacterial characterisation 419 
In order to test the potential antimicrobial activity of THC infiltrated disks as an additional 420 
feature of this material, we performed antimicrobial plate assays with disk-shaped 421 
scaffolds (8 mm diameter) in the presence of the common nosocomial and joint-422 
replacement/ wound infecting organisms S. aureus and P. aeruginosa. As shown in 423 
Figure 8, there was a slight antimicrobial action exhibited by the THC containing scaffolds 424 
with S. aureus in the area where the disks were placed (i.e. with the THC there was a 425 
less dense growth), seen by individual colonies being visible, whereas without the THC 426 
the bacteria grew all the way up to the scaffold. The same did not apply for P. aeruginosa. 427 
We therefore have preliminary evidence that these materials have possible antimicrobial 428 
capability that could augment their potential for clinical use in orthopaedic surgery, 429 
because S. aureus strains represent a significant proportion of all pathogens causing 430 
infections associated with orthopaedic implants, and the binding of S. aureus to host 431 
tissues and plasma proteins is of critical importance in the development of infections at 432 
the implant site [65]. 433 
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4. Conclusions 434 
This study demonstrated the utility of lactose cross-linking and THC to modify and 435 
improve the physico-chemical properties of gelatin-based porous scaffolds for tissue 436 
engineering. The cross-linking reaction resulted in a more water stable scaffold with 437 
enhanced mechanical properties and high water uptake capacity (> 800%). Although 438 
porosity decreased with the increase of the initial gelatin concentration, the observed 439 
increase of pore size from 118 ± 40 µm to 254 ± 57 µm, along with the cross-linking 440 
reaction, reinforced the scaffolds, enhancing their mechanical properties. Results of in 441 
vitro THC release and antibacterial experiments demonstrated that the THC-loaded 442 
scaffolds were capable of effectively releasing THC in a controlled way, with 80% THC 443 
released within three days that may lead to the design of an appropriate drug delivery 444 
method for the postoperative inflammation and pain management. Looking forward to the 445 
intended clinical use, the main advantage of the system reported here was the THC 446 
biocompatibility and antimicrobial potential with a tailored concentrations for relatively 447 
rapid release to achieve a therapeutic effect minimising the risk of systemic side effects. 448 
This study has therefore demonstrated that THC may be applied to the manufacture of 449 
medical devices, particularly embedded in gelatin porous scaffolds, and it possesses 450 
potential antimicrobial properties to augment its’ musculoskeletal applications. 451 
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Figure captions 459 
Figure 1 ATR-FTIR spectra of non-heated (NH), heat-treated (HT) and HT-THC 460 
scaffolds with (A) 2.5 and (B) 4% w/v gelatin; (C) measurement of the areas of the bands 461 
at 1624 cm-1, 1650 cm-1, and 1680 cm-1 as a function of protein concentration and heat 462 
treatment. 463 
Figure 2 (A) Stress-strain curves of non-heated (NH), heat-treated (HT) and HT-THC 464 
scaffolds with 2.5 and 4% w/v gelatin. (B) Young’s modulus and stress values 465 
(calculated at 40% strain). Two means followed by the same letter in the same 466 
parameter are not significantly (p > 0.05) different through the Tukey’s multiple range 467 
test. n = 3 is the minimum number of replications. 468 
Figure 3 SEM micrographs of (A) non-heated (NH), (B) heat-treated (HT) and (C) HT-469 
THC scaffolds with 2.5% w/v gelatin and (D) NH, (E) HT and (F) HT-THC scaffolds with 470 
4% w/v gelatin. Bar = 200 µm. 471 
Figure 4 (A) Average pore size (µm) and (B) pore size distribution (%) of non-heated 472 
(NH) heat-treated (HT) and HT-THC scaffolds with 2.5 and 4% w/v gelatin. 473 
Figure 5 Water uptake (WU) values for heat-treated (HT) and HT-THC scaffolds with (A) 474 
2.5 and (B) 4% w/v gelatin. (C) Scaffold degradation degree (DD) values calculated after 475 
immersion in PBS for different interval times. Two means followed by the same letter are 476 
not significantly (p > 0.05) different through the Tukey’s multiple range test. n = 3 is the 477 
minimum number of replications. 478 
Figure 6 THC release from heat-treated (HT) scaffolds with 2.5 and 4% w/v gelatin. 479 
Figure 7 Metabolic activity and morphological study of cells seeded on the porous 480 
scaffolds. PrestoBlue assay of cells cultured on (A) 2.5% w/v and (B) 4% w/v gelatin 481 
porous scaffolds after 1, 3, 7 and 14 days. (C) Confocal microscopy images of 482 
chondrocytes cells after 3 and 7 days of culture. Scale bars: 75 μm. 483 
Figure 8 Representative macro-photograph showing growth inhibition of (A) 484 
Pseudomonas aeuroginosa and (B) Staphylococcus aureus  at 24 h by 2.5% w/v gelatin 485 
without and with THC addition (a and c), and 4% w/w gelatin without and with THC 486 
addition (b and d). 487 
Scheme 1. The early stage of the cross-linking reaction (gal=galactose). 488 
 489 
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Figure 1 492 
 493 
  494 
C
Gelatin 
concentration
Scaffold 1624 cm-1 1650 cm-1 1680 cm-1
NH 35.7 60.1 4.2
2.5% w/v HT 42.1 52.3 5.6
HT-THC 40.9 54.4 4.7
NH 35.5 59.4 5.1
4.0% w/v HT 48.2 44.3 7.5
HT-THC 46.9 46.3 6.8
A B
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 498 
 499 
  500 
Scaffold Stress (MPa) Young’s modulus (MPa)
2.5% w/v 4.0% w/v 2.5% w/v 4.0% w/v
NH 0.173  0.006a 0.282  0.04c 1.22  0.18a 1.51  0.04ab
HT 0.232  0.011bc 0.377  0.050d 1.42  0.18ab 2.43  0.48c
HT-THC 0.155  0.003a 0.289  0.014c 0.92  0.22a 2.04  0.18bc
A
B
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Figure S1. Freeze-drying process, as a function of initial gelatin (concentration, to 
obtain the scaffolds. 
 
 
 
 
 
Figure S2 Non-heated (NH), heat-treated (HT) and HT-THC scaffolds with 2.5 % w/v 
gelatin immersed into PBS at 37 ºC as a function of time.  
 
